USD27.36
well being https://hips.hearstapps.com/hmg-prod/images/mh-8-11-supplements-64d65b9d1cbdd.png?crop=0.888888888888889xw:1xh;center,top&resize=1200:* B12 Injection Before and After: What Changes & When Size:250 Grams GHRH Peptide Comparison Table Property Tesamorelin Sermorelin CJC-1295 (No DAC) CJC-1295 DAC FDA Status ✅ FDA Approved (Egrifta) ❌ Previously approved, now discontinued ❌ Not approved ❌ Not approved Amino Acids 44 (modified GHRH) 29 (GHRH 1-29) 29 + modifications 29 + Drug Affinity Complex Half-Life ~26-38 minutes ~10-20 minutes ~30 minutes ~6-8 days Mechanism GHRH receptor agonist GHRH receptor agonist GHRH receptor agonist GHRH receptor agonist (extended) Clinical Trial Data Extensive (Phase 3 completed) Limited (older studies) Limited (Phase 1/2) Limited Primary Research Use Lipodystrophy, NAFLD, body composition GH deficiency research GH axis research Extended GH release research Key Differentiators Tesamorelin's advantages: Only GHRH analog with current FDA approval Extensive Phase 3 clinical trial data Documented efficacy for visceral fat reduction Well-characterized safety profile from prescription use Sermorelin note: Previously FDA-approved (1997) for pediatric growth hormone deficiency but discontinued by manufacturers — no longer available as a prescription product in the US
USD27.36
USD28.90
USD21.09
USD28.67
USD22.64
USD25.15
USD23.86
Explain the specific unanswered question affecting your decision if helpful. Keep any extension acknowledgment with the original offer details.
Confirm unusual requirements with the seller before submitting them as order notes. If a mistake is discovered, use the official correction process promptly.
Identify which term affects your decision rather than treating every unfamiliar word as essential. Ask a focused follow-up if the explanation simply repeats the original word.